FREE SHIPPING 
for orders over 250$ 

Peptides

Purchase Legit Pharmacy Peptides and medications online - CJC-1295GHRP , HexarelinIpamorelin , Sermorelin


Product Compare (0)


CJC-1295 DAC - 2mg Magnus Pharma

PRODUCT NAME: CJC-1295 DAC 2MGSUBSTANCE: PEPTIDEMANUFACTURER: MAGNUS PHARMACEUTICALSProduct DescriptionCJC 1295 with DAC Peptide Magnus PharmaceuticalsThe CJC 1295 with DAC Peptide Magnus Pharmaceuticals is a so-called GHRH peptide. That is, It ensures an increased release of body growth hormone. As well as an increase in the body‘s concentration of IGF-1. These peptides are well suited to build more muscle mass and also to reduce the body fat percentage over the long term.CJC 1295 with DAC Peptide Magnus Pharmaceuticals has a very long half-life of several days. It significantly increases the release of growth hormone by the adenohypophysis.CJC 1295 with DAC Peptide Magnus Pharmaceuticals is, so to speak, the „extended release“ variant of a GHRH peptide. In the long term, it supports the body‘s secretion of growth hormone at a higher level. For example, for a generally better well-being.The Benefits of CJC 1295 with DAC Peptide Magnus Pharmaceuticals:Increased sexual drive CJC 1295 with DAC Peptide Magnus PharmaceuticalsImprovement of the immune system by CJC 1295 with DAC Peptide Magnus Pharmaceuticals applicationCJC 1295 with DAC Peptide Magnus Pharmaceuticals radically increases the IGF1 productionImprovement of bone density by CJC 1295 with DAC Peptide Magnus PharmaceuticalsCJC 1295 with DAC Peptide Magnus Pharmaceuticals increases protein synthesisImprovement of organ functions by CJC 1295 with DAC Peptide Magnus PharmaceuticalsReduction of abdominal fat by CJC 1295 with DAC Peptide Magnus Pharmaceuticals CureImproves energy and vitality with CJC 1295 with DAC Peptide Magnus PharmaceuticalsCJC 1295 with DAC Peptide Magnus Pharmaceuticals improves the skin toneImproves endurance with CJC 1295 with DAC Peptide Magnus PharmaceuticalsAccelerates wound healing by CJC 1295 with DAC Peptide Magnus PharmaceuticalsCJC 1295 with DAC Peptide Magnus Pharmaceuticals strengthens the heartIncreases sleep quality CJC 1295 with DAC Peptide Magnus PharmaceuticalsPositive effects on the eyes CJC 1295 with DAC Peptide Magnus PharmaceuticalsCJC 1295 with DAC Peptide Magnus Pharmaceuticals is structurally closely related to the body-specific GHRH peptide hormone.However, since GHRH itself is quite expensive and expensive to produce and has only an extremely short time of action, it is generally not used by users, for example bodybuilders or other athletes. The American / Canadian biotechnology company ConjuChem therefore developed a modified new peptide, comprising the first 29 amino acids of GHRH, starting from the structure of the natural, 44 amino acid GHRHs. In addition, a so-called DAC ( „drug affinity complex“) based on the amino acid lysine was added to the new peptide in a method developed by ConjuChem.This DAC prevents the early degradation (degradation) of the peptide and increases the half-life by drastically up to 7 days by the peptide selectively binding to freely circulating albumin during the so-called bioconjugation after injection. Due to this, the concentration of CJC 1295 with DAC Peptide Magnus Pharmaceuticals remains at a uniform level after injection, which gradually decreases over several days.CJC 1295 with DAC Peptide Magnus Pharmaceuticals strengthens the body‘s secretion of growth hormones:The acute delivery of the peptide itself does not elicit an immediate growth hormone pulse in the adenohypophysis. Instead, the peptide continues to increase the amplitude of naturally-distributed waves of growth hormone secretion throughout the day. Furthermore, CJC 1295 with DAC Peptide Magnus Pharmaceuticals also increases the production of IGF-1 in the liver. This results in further anabolic (and thus desirable for athletes) desirable effects.While normally an increase in growth hormone secretion also provides an increase in the concentration of the hormone prolactin, it remains within the scope of the supply of CJC 1295 with DAC Peptide Magnus Pharmaceuticals. High prolactin values reduce libido in men and can lead to impotence as well as mental problems (especially impotence).Since CJC 1295 with DAC Peptide Magnus Pharmaceuticals improves the secretion of growth hormone as well as prevents prolactin concentration increase, the protein biosynthesis in the body also proceeds more efficiently. This also promotes the development of new muscle masses. Furthermore, CJC 1295 with DAC Peptide Magnus Pharmaceuticals can also trigger the breakdown (lipolysis) of adipose tissue by its effect on growth hormone secretion. Increase bone density or promote cell renewal in damaged or aged tissue.When, how and for what is CJC 1295 with DAC Peptide Magnus Pharmaceuticals used and dosed?As described above, CJC 1295 with DAC Peptide Magnus Pharmaceuticals ensures that the adenohypophysis releases larger amounts of growth hormone over a longer period of time.Therefore, the peptide is particularly suitable for users who are not able to inject frequently and for users. Want to find a basic way to increase their growth hormone concentration. Instead of reaching a point-by-point maximization of growth hormone secretion.In this way, the peptide provides in the background, so to speak, for the user to achieve better results in terms of muscle build-up or fat loss. If the other factors in the execution of your own training and nutritional plan are also consistent in themselves and are adhered to.As a rule, CJC 1295 with DAC Peptide Magnus Pharmaceuticals is injected twice a week (every 3 to 4 days) with 1 mg each.The best time for injection of CJC 1295 with DAC Peptide Magnus Pharmaceuticals is in itself before going to bed. Since the peptide, according to many reports, can also provide for a relaxing and regenerative effective sleep.Side effects are rarely associated with the use of CJC 1295 with DAC Peptide Magnus Pharmaceuticals. There may be joint pain or slight numbness in the hands and feet.Muscle Mass Composition Combination Mod GRF 1-29 and CJC 1295 with DAC Peptide Magnus Pharmaceuticals:Thus, as can be seen, both CJC 1295 with DAC Peptide Magnus Pharmaceuticals and Mod GRF 1-29 are thus GHRH peptides with identical mode of action. Their difference is due to their widely differing half-life. This allows for the repeated injection of the peptide several times a day (and makes it practically necessary for meaningful results at the same time). At least 3 hours should elapse between injections.The number of injections can be adapted to individual wishes and needs. And moves with most users between 2 and 3 times a day. Investigations have shown that a dose of 100 mcg Mod GRF 1-29 is sufficient to completely occupy the corresponding receptors in the adenohypophysis. Thus, the injection of more than 100 mcg of Mod GRF 1-29 at once results in only a slight increase in the effect of secretion of additional growth hormone.What makes sense, however, is the combination of Mod GRF 1-29 with a GHRP peptide, e.g. GHRP-6.There is a strong synergy between these types of peptides. While the GHRP peptide triggers a growth hormone pulse, it is amplified by Mod GRF 1-29. For example, the supply of 100 mcg of GHRP-6 and 100 mcg of Mod GRF 1-29 leads to the same secretion of growth hormone as if 300 mcg of GHRP-6 had been added. In general, the combination of Mod GRF 1-29 and a GHRP peptide makes sense for all users who want to dispense with expensive – and often fake – synthetic HGH. The use of these peptides stimulates and enhances the body‘s production of growth hormone rather than externally adding growth hormone. Because of this more natural course for the body, Mod GRF 1-29 does not necessarily have to be gecycled, but can also be used theoretically permanently...

$52.00

CJC-1295 DAC 2mg

PRODUCT USAGE:THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY.This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All the product information available on this website is for educational purposes only. Bodily introduction of any kind into huans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabled as a drug, food or cosmetics.CJC-1295 DAC 2mg PeptideSequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-LysLys(Maleimidopropionyl)-NH2 (Drug Affinity Complex) Molecular formula: C165H269N47O46Molar Mass: 3647.15CAS number: 863288-34-0CJC-1295 DAC..

$26.00

Follistatin-344 Peptide Magnus Pharma

Manufacturer: MagnusQuantity: 1mgPackage: 10mlSteroid cycle: growthActive principle: Follistatin 344Product DescriptionFollistatin-344 Peptide Magnus PharmaceuticalsFollistatin-344 Peptide Magnus Pharmaceuticals is a specific protein or peptide. It specifically inhibits the release of the quasi-negative stimulating hormone myostatin (Myostatin blockers). Which is responsible for the limitation of the muscle build-up, as well as for the breakdown of musculature. Follistatin is therefore the opponent of Myostatin. Follistatin-344 Peptide Magnus Pharmaceuticals is therefore a naturally occurring peptide. Follistatin-344 Peptide Magnus Pharmaceuticals is an extremely potent and effective myostatin inhibitor (myostatin blocker).The Benefits of Follistatin-344 Peptide Magnus Pharmaceuticals:Follistatin-344 generally provides for the increase of muscle massIncreased Strength and Endurance by Follistatin-344 Magnus PharmaceuticalsIncrease in the overall muscle volume by the myostatin blocker Follistatin-344 Peptide Magnus PharmaceuticalsFollistatin-344 Peptide Magnus Pharmaceuticals provides greater muscular strain, resulting in more growthThe myostatin blocker Follistatin-344 Peptide Magnus Pharmaceuticals improves sleepThe peptide Follistatin-344 Peptide Magnus Pharmaceuticals additionally strengthens the joints and the connective tissueFollistatin-344 strongly supports fat burningThe effect of Follistatin-344 Peptide Magnus Pharmaceuticals:As already briefly mentioned, myostatin promotes the breakdown of so-called myotubes, ie skeletal muscle fibers. This ultimately results both in the inhibition of muscle building and in general in muscle breakdown. In addition, the protein myostatin controls muscle muscle growth by preventing uncontrolled growth of the skeletal muscle. Follistatin-344 Peptide Magnus Pharmaceuticals plays the leading role in the regulation of myostatin. It acts like a very precise filter in the skeletal muscle and filters the muscle-building-inhibiting proteins. This is how the name Myostatin Hemmer comes about.Use Follistatin-344 Peptide Magnus Pharmaceuticals as Myostatin Blocker:Most peptides are designed to increase the body‘s growth hormone distribution. In collaboration with exogenous or body-borne testosterone and insulin to form the maximum level of IGF-1. In order to achieve maximum muscle growth. But now the research is as far as to deal with peptides, which inhibit the production of myostatin.Ingestion and ingestion of Follistatin-344 Peptide Magnus Pharmaceuticals:According to the US forums, the most promising doses of 100mcg daily for 10 days, with a subsequent 10-day break. This cycle is repeated as desired. Another very low dosage is given to the injection of 100mcg every 10 days. In addition, the combination with GHRP 2 or GHRP 6 or the use of PEG MGF is recommended to increase the anabolic effects of Follistatin-344 Peptide Magnus Pharmaceuticals and to protect the joints and vision...

$74.00

GHRP-2 10mg Magnus Pharma

GHRP-2GHRP-2 (also known as KP 102 or Pralmorelin) is a synthetic hexapeptide Growth Hormone Releasing Peptide (GHRP), which acts on the hypothalamus and the pituitary gland to release growth hormone with a slight stimulator effect on Prolactin, ACTH and Cortisol levels. GHRP-2 is considered to be a true hGH secretagogue, meaning that it stimulates the body’s own secretion of hGH. Human Growth hormone has been shown in studies to promote lean body mass and reduce adiposity (fat). GHRP2 has demonstrated that it is very effective at stimulating GH production in research test subjects. It has a short half life with peak concentrations occurring around 15 minutes and not longer than 60 minutes after administration. GHRP-2 PeptideSequence: H-D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2Molecular formula: C45H55N9O6Molar Mass: 817.9CAS number: 158861-67-7PubChem: CID 6918245 Synonyms: Growth Hormone Releasing Peptide-2; GHRP2; GHRP 2GHRP2 (Growth Hormone Releasing Peptide 2) also known as PralmorelinGHRP-2 and GRF Analogue Interactions (CJC-1295 / Sermorelin)It is important to know that GHRP-2 does not relate to any Growth Hormone Releasing Hormones (GHRH) peptides such as Sermorelin and CJC-1295 because it acts on different receptors. However, greater results occurred when administered in conjunction with a Growth Hormone Releasing Hormone (GHRH) such as Modified GRF 1-29 or CJC-1295 DAC. Naturally, these GHRP-2 peptide receptors interact with a hormone called ghrelin. Growth hormone releasing peptide 2 is a commercially synthesized, non-natural super-analog of GHRP-6 which is capable of potent stimulatory effect on growth hormone (GH) secretion with slight stimulator effect in PRL, ACTH and levels of cortisol (Arvat et al. 1997). It is also a synthetic agonist of ghrelin that is binding with the growth hormone (GH) secretagogue receptor. GHRP-2 has been shown to affect and induce growth hormone secretion. The response of natural physiologic system includes increase in levels of calcium ion influx alongside with increased release of growth hormones in response to this peptide (Wu et al. 1994). Comparing GHRP-2 and GHRP-6 (Growth Hormone Releasing Hexapeptide)GHRP-2 is a 2nd generation GHRP just behind GHRP-6. Compared to GHRP-6, GHRP-2 is considered to be much more superior in terms of growth hormone stimulation because over longer periods of time it maintains maximum elevations in Growth Hormone. GHRP-2 has shown to increase IGF-1 levels (Insulinlike Growth Factor 1), and even greater results happen when used with Growth Hormone Releasing Hormone (GHRH). It has a short half life with peak concentrations occurring around 15 minutes but not longer than 60 minutes. The response of natural physiologic system includes increase in levels of calcium ion influx alongside with increased release of growth hormones in response to the high-amplitude pulsation from the GHRP-2. GHRP-2 and other ghrelin analogues increase the number of somatotropes involved in the GH pulse by inhibiting somatostatin, GHRH increases the pulse amplitude per pituitary cell or somatotrope by other means. Unlike ghrelin, GHRP-2 is not lipogenic which means that it does not induce fat storage. Although ghrelin plays a large role in hunger, GHRP-2 as an analog of ghrelin does not increase appetite significantly. The Utility of GHRP-2 as a Growth Hormone SecretagogueGHRP-2 has been studied extensively for its utility as a growth hormone secretagogue (GHS). Scientists have discovered that the Growth Hormone Releasing Peptide-2 increases the natural production of growth hormone (GH). In the early 90’s, one of the most famous studies was performed and later published in 1997 in the Journal of Endocrinology and Metabolism. This study further exemplifies the theory that growth hormone releasing peptides (including Ipamorelin and GHRP-6) could help hormone deficient adults and children. Ever since these major scientific studies, GHRP-2 has been widely produced. With other scientific labs confirming the results from their studies, GHRP-2 can in fact work for those who lack the ability to make adequate human growth hormone. Results however will differ with the use of GHRP-2 because species respond differently based on the pituitary somatotrophs and the differences in the subtypes of GHRP receptors. In the physiologic system, the actions are blocked by GRF receptors antagonist which acts through a different receptor to that employed by earlier GHRPs...

$42.00

GHRP-2.5mg

GHRP-2.5mg PRODUCT USAGE:THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY.This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All the product information available on this website is for educational purposes only. Bodily introduction of any kind into huans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabled as a drug, food or cosmetics.GHRP-2GHRP-2 (also known as KP 102 or Pralmorelin) is a synthetic hexapeptide Growth Hormone Releasing Peptide (GHRP), which acts on the hypothalamus and the pituitary gland to release growth hormone with a slight stimulator effect on Prolactin, ACTH and Cortisol levels. GHRP-2 is considered to be a true hGH secretagogue, meaning that it stimulates the body’s own secretion of hGH. Human Growth hormone has been shown in studies to promote lean body mass and reduce adiposity (fat). GHRP2 has demonstrated that it is very effective at stimulating GH production in research test subjects. It has a short half life with peak concentrations occurring around 15 minutes and not longer than 60 minutes after administration.GHRP-2 PeptideSequence: H-D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2Molecular formula: C45H55N9O6Molar Mass: 817.9CAS number: 158861-67-7PubChem: CID 6918245 Synonyms: Growth Hormone Releasing Peptide-2; GHRP2; GHRP 2GHRP2 (Growth Hormone Releasing Peptide 2) also known as PralmorelinGHRP-2 and GRF Analogue Interactions (CJC-1295 / Sermorelin)It is important to know that GHRP-2 does not relate to any Growth Hormone Releasing Hormones (GHRH) peptides such as Sermorelin and CJC-1295 because it acts on different receptors. However, greater results occurred when administered in conjunction with a Growth Hormone Releasing Hormone (GHRH) such as Modified GRF 1-29 or CJC-1295 DAC. Naturally, these GHRP-2 peptide receptors interact with a hormone called ghrelin. Growth hormone releasing peptide 2 is a commercially synthesized, non-natural super-analog of GHRP-6 which is capable of potent stimulatory effect on growth hormone (GH) secretion with slight stimulator effect in PRL, ACTH and levels of cortisol (Arvat et al. 1997). It is also a synthetic agonist of ghrelin that is binding with the growth hormone (GH) secretagogue receptor. GHRP-2 has been shown to affect and induce growth hormone secretion. The response of natural physiologic system includes increase in levels of calcium ion influx alongside with increased release of growth hormones in response to this peptide (Wu et al. 1994).Comparing GHRP-2 and GHRP-6 (Growth Hormone Releasing Hexapeptide)GHRP-2 is a 2nd generation GHRP just behind GHRP-6. Compared to GHRP-6, GHRP-2 is considered to be much more superior in terms of growth hormone stimulation because over longer periods of time it maintains maximum elevations in Growth Hormone. GHRP-2 has shown to increase IGF-1 levels (Insulinlike Growth Factor 1), and even greater results happen when used with Growth Hormone Releasing Hormone (GHRH). It has a short half life with peak concentrations occurring around 15 minutes but not longer than 60 minutes. The response of natural physiologic system includes increase in levels of calcium ion influx alongside with increased release of growth hormones in response to the high-amplitude pulsation from the GHRP-2. GHRP-2 and other ghrelin analogues increase the number of somatotropes involved in the GH pulse by inhibiting somatostatin, GHRH increases the pulse amplitude per pituitary cell or somatotrope by other means. Unlike ghrelin, GHRP-2 is not lipogenic which means that it does not induce fat storage. Although ghrelin plays a large role in hunger, GHRP-2 as an analog of ghrelin does not increase appetite significantly.The Utility of GHRP-2 as a Growth Hormone SecretagogueGHRP-2 has been studied extensively for its utility as a growth hormone secretagogue (GHS). Scientists have discovered that the Growth Hormone Releasing Peptide-2 increases the natural production of growth hormone (GH). In the early 90’s, one of the most famous studies was performed and later published in 1997 in the Journal of Endocrinology and Metabolism. This study further exemplifies the theory that growth hormone releasing peptides (including Ipamorelin and GHRP-6) could help hormone deficient adults and children. Ever since these major scientific studies, GHRP-2 has been widely produced. With other scientific labs confirming the results from their studies, GHRP-2 can in fact work for those who lack the ability to make adequate human growth hormone. Results however will differ with the use of GHRP-2 because species respond differently based on the pituitary somatotrophs and the differences in the subtypes of GHRP receptors. In the physiologic system, the actions are blocked by GRF receptors antagonist which acts through a different receptor to that employed by earlier GHRPs...

$14.00

GHRP-6 10mg Magnus Pharma

GHRP-6GHRP-6 is a potent stimulator of natural Growth Hormone release. GHRP-6 is a Hexa-peptide that promotes food intake by stimulating hunger and helps increase energy metabolism. Growth Hormone Releasing Peptides, similar to GHRP-6, are most commonly used for treatment of Growth Hormone (GH) deficiencies, eating disorders, obesity, etc. Research has shown that use of these HGH Peptides increases lean muscle mass, strength, stamina and decreases body fat.GHRP-6 PeptideSequence: His-D-Trp-Ala-Trp-D-Phe-Lys-NH2Molecular formula: C46H56N12O6Molar Mass: 873.014 CAS number: 87616-84-0 PubChem: 5486806 Synonyms: Growth Hormone Releasing Peptide-6; GHRP6; GHRP 6Growth Hormone Releasing HexapeptideThe Development of GHRP-6In 1982, the natural hormone "Growth Hormone Releasing Hormone" (GHRH) was identified after a prolonged search. Soon, researchers discovered that those GH-Releasing Peptides (specifically GHRP-6 & GHRP-2) followed a mode of action which bound them to and was mediated through receptors different from those for GHRH. Furthermore, researches discovered that these GH-Releasing Peptides acted synergistically with the natural hormone Growth Hormone Releasing Hormone (GHRH), which is related to Sermorelin, in both laboratory animals and humans to produce large releases of Growth Hormone. In the 1980s, the first highly potent GH-Releasing peptide, GHRP-6, was developed. Due to a strong GH release response from the the peptide, it became the first member of a class called Growth Hormone secretagogues. GHRP-6 is a hexapeptide composed of 6 amino acids: L-Histidine, D-Tryptophan, L-Alanine, L-Tryptophan, D-Phenylalanine and L-Lysine. The "L" form of an amino acid is the naturally occurring form and often in the nomenclature the "L" is dropped. The "D" form does not occur in nature and is the isomeric form (i.e. mirror image) of the naturally occurring "L" form. GHRP-6 (His-D-Trp-Ala-Trp-D-Phe-Lys-NH2) is composed of both natural and isomeric forms of those 6 amino acids.This sequence provides a signal to the body to begin secreting Growth Hormone release while also blocking Somatostatin, a hormone that inhibits the release of Growth Hormone.Studies Related to the GHRP-6 PeptideInvestigations reported that GHRP-6 is more efficient than GHRH itself in monkeys and performs synergistically when combined or applied together. An example of this combination would be GHRP-2 and CJC-1295. GHRP-6 is believed to be acting naturally on both pituitary and hypothalamic sites (Fairhall et al. 1995). In a time-dependent and dose-dependent manner, the primary pituitary cells of rats were demonstrated on. From the studies, the concentrations of the GHRP-6 needed for the half-maximal and maximal stimulation were 7 x 10(-9) and 10(-7) M, respectively.In another study, it was concluded that the major target of the GHRP-6 in vivo (both laboratory animals and humans) is the hypothalamus. From the observation, it was concluded that the GH release induced by the central GHRP-6 injections in guinea pigs was inhibited by the central action of somatostatin. Furthermore, an inhibition by somatostatin with the activated GRF neurons, induced by GHRP-6, was observed via receptors known to be located on or near the GRF themselves. This particular experiment further indicated that GHRP-6 is effectively stimulating GH release from somatotrophs through different receptors, the mechanisms of which are not yet known (Chan et al. 1989).Determining how efficient and the actions of the growth hormone is dependent on the physical condition of the experimental unit. For example, in humans, GH secretion decreases with obesity. On the other hand, GHRP-6, similar to Hexarelin, showed in one case increased (almost twice that of GHRP) GH responses when administered in obese patients (Cordido et al. 1993). Though obesity has shown affecting the efficiency of the hormone, it was also suggested that GHRP-6’s effects were found to be sex- and age-independent without being affected by the noadregenic pathways using the a2 adrenergic receptors (Penalva et al. 2008).GHRP-6 and the Growth Hormone Secretagogue ReceptorGHRPs are not simply surrogates of GHRH, instead GHRP-6 is an artificial activator of a separate newly discovered receptor called Growth Hormone Secretagogue Receptor (GHS-R). Soon Ghrelin was discovered, the endogenous ligand that binds to the GHS-R. Both Ghrelin and all the synthetic compounds such as GHRP-6 were termed "Growth Hormone Secretagogues" (GHSs). One side effect of GHRP-6 is a significant increase in appetite due to stimulating the release of Ghrelin, a peptide that is released naturally in the lining of the stomach that increases hunger and gastric emptying. Also, GHRP-6 causes stimulation of the anterior pituitary gland which causes an increase in Growth Hormone release. The increased amounts of Growth Hormone can cause the liver to secrete the hormone IGF-1, which improves the animal body’s ability to burn fat and build muscle. Since GHRP-6 acts directly on the feedback loop which signals the inhibition of Growth Hormone release, GHRP-6 can re-stimulate the production of Growth Hormone...

$42.00

GHRP-6.5mg

PRODUCT USAGE:THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY.This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All the product information available on this website is for educational purposes only. Bodily introduction of any kind into huans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabled as a drug, food or cosmetics.GHRP-6GHRP-6 is a potent stimulator of natural Growth Hormone release. GHRP-6 is a Hexa-peptide that promotes food intake by stimulating hunger and helps increase energy metabolism. Growth Hormone Releasing Peptides, similar to GHRP-6, are most commonly used for treatment of Growth Hormone (GH) deficiencies, eating disorders, obesity, etc. Research has shown that use of these HGH Peptides increases lean muscle mass, strength, stamina and decreases body fat.GHRP-6 PeptideSequence: His-D-Trp-Ala-Trp-D-Phe-Lys-NH2Molecular formula: C46H56N12O6Molar Mass: 873.014 CAS number: 87616-84-0 PubChem: 5486806 Synonyms: Growth Hormone Releasing Peptide-6; GHRP6; GHRP 6Growth Hormone Releasing HexapeptideThe Development of GHRP-6In 1982, the natural hormone "Growth Hormone Releasing Hormone" (GHRH) was identified after a prolonged search. Soon, researchers discovered that those GH-Releasing Peptides (specifically GHRP-6 & GHRP-2) followed a mode of action which bound them to and was mediated through receptors different from those for GHRH. Furthermore, researches discovered that these GH-Releasing Peptides acted synergistically with the natural hormone Growth Hormone Releasing Hormone (GHRH), which is related to Sermorelin, in both laboratory animals and humans to produce large releases of Growth Hormone. In the 1980s, the first highly potent GH-Releasing peptide, GHRP-6, was developed. Due to a strong GH release response from the the peptide, it became the first member of a class called Growth Hormone secretagogues. GHRP-6 is a hexapeptide composed of 6 amino acids: L-Histidine, D-Tryptophan, L-Alanine, L-Tryptophan, D-Phenylalanine and L-Lysine. The "L" form of an amino acid is the naturally occurring form and often in the nomenclature the "L" is dropped. The "D" form does not occur in nature and is the isomeric form (i.e. mirror image) of the naturally occurring "L" form. GHRP-6 (His-D-Trp-Ala-Trp-D-Phe-Lys-NH2) is composed of both natural and isomeric forms of those 6 amino acids.This sequence provides a signal to the body to begin secreting Growth Hormone release while also blocking Somatostatin, a hormone that inhibits the release of Growth Hormone.Studies Related to the GHRP-6 PeptideInvestigations reported that GHRP-6 is more efficient than GHRH itself in monkeys and performs synergistically when combined or applied together. An example of this combination would be GHRP-2 and CJC-1295. GHRP-6 is believed to be acting naturally on both pituitary and hypothalamic sites (Fairhall et al. 1995). In a time-dependent and dose-dependent manner, the primary pituitary cells of rats were demonstrated on. From the studies, the concentrations of the GHRP-6 needed for the half-maximal and maximal stimulation were 7 x 10(-9) and 10(-7) M, respectively.In another study, it was concluded that the major target of the GHRP-6 in vivo (both laboratory animals and humans) is the hypothalamus. From the observation, it was concluded that the GH release induced by the central GHRP-6 injections in guinea pigs was inhibited by the central action of somatostatin. Furthermore, an inhibition by somatostatin with the activated GRF neurons, induced by GHRP-6, was observed via receptors known to be located on or near the GRF themselves. This particular experiment further indicated that GHRP-6 is effectively stimulating GH release from somatotrophs through different receptors, the mechanisms of which are not yet known (Chan et al. 1989).Determining how efficient and the actions of the growth hormone is dependent on the physical condition of the experimental unit. For example, in humans, GH secretion decreases with obesity. On the other hand, GHRP-6, similar to Hexarelin, showed in one case increased (almost twice that of GHRP) GH responses when administered in obese patients (Cordido et al. 1993). Though obesity has shown affecting the efficiency of the hormone, it was also suggested that GHRP-6’s effects were found to be sex- and age-independent without being affected by the noadregenic pathways using the a2 adrenergic receptors (Penalva et al. 2008).GHRP-6 and the Growth Hormone Secretagogue ReceptorGHRPs are not simply surrogates of GHRH, instead GHRP-6 is an artificial activator of a separate newly discovered receptor called Growth Hormone Secretagogue Receptor (GHS-R). Soon Ghrelin was discovered, the endogenous ligand that binds to the GHS-R. Both Ghrelin and all the synthetic compounds such as GHRP-6 were termed "Growth Hormone Secretagogues" (GHSs). One side effect of GHRP-6 is a significant increase in appetite due to stimulating the release of Ghrelin, a peptide that is released naturally in the lining of the stomach that increases hunger and gastric emptying. Also, GHRP-6 causes stimulation of the anterior pituitary gland which causes an increase in Growth Hormone release. The increased amounts of Growth Hormone can cause the liver to secrete the hormone IGF-1, which improves the animal body’s ability to burn fat and build muscle. Since GHRP-6 acts directly on the feedback loop which signals the inhibition of Growth Hormone release, GHRP-6 can re-stimulate the production of Growth Hormone...

$14.00

Hexarelin 5mg KNOLL

PRODUCT USAGE:THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY.This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All the product information available on this website is for educational purposes only. Bodily introduction of any kind into huans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabled as a drug, food or cosmetics.HexarelinHexarelin (Hexarelin Acetate) is a synthetic hexapeptide in the growth factor family which stimulates the release of growth hormone (GH) and does not interfere with the body's ability to produce its own GH. Structurally, Hexarelin (Hexarelin Acetate) is similar in structure to GHRP-6 but without the appetite increase because of its inability to drastically increase Ghrelin levels which is responsible for the increased appetite and quicker gastric emptying. Hexarelin is a synthetic growth hormone secretagogue made from six amino acids. It contains powerful growth hormone releasing properties in the human body. Hexarelin in studies over a certain period has shown that it reduces visceral fat. Hexarelin (Hexarelin Acetate) like other Growth Hormone Releasing Peptides is most effective synergistically when administered with GHRH such as Sermorelin or Modified GRF 1-29. The increase of circulating GH through Hexarelin use causes levels of Insulin-Like Growth Factor (IGF-1) to rise in the liver. IGF-1 is the prime cause of muscle growth in response to GH stimulation. Users of IGF-1 typically experience increased strength and muscle mass, as well as a very pronounced fat loss.Hexarelin Acetate StructureSequence: His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2Molecular formula: C47H58N12O6Molar Mass: 887.04022CAS number: 140703-51-1PubChem: CID 5464109Synonyms: Hexarelin Acetate, HEX, ExamorelinHexarelin AcetateThe functionality of HexarelinHexarelin (Hexarelin Acetate) is chemically designed as L-Histidyl-2-methyl-D-tryptophyl-L-alanyl-L-tryptophyl-D-phenylalanyl-L-lysinamide. Hexarelin (Hexarelin Acetate) is a potent GHRP-6 analog, whose structure (His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2) creates a greater stability than GHRP-6 due to a substituted (2 Me)Trp. Hexarelin has a half-life of about 70 min, longer than that of GHRP-6. Replacement of the naturally occurring L-amino acids for the D-configuration results in these longer half-lives.Growth Hormone SecretionHexarelin has shown that it is highly stimulated at 30 minutes after being induced by rapid and sustained GH secretion. The pituitary gland produces GH in the brain, in children this hormone helps them to grow and in adults it helps to maintain muscle and burn fat. In one sixteen-week study, it has been shown that GH levels return to normal after stopping use after four weeks...

$18.00

HGH FRAGMENT 2MG MAGNUS

HGH FRAGMENT 2MGUnit Size 2 mg/vialUnit Quantity 1 vialPurity (HPLC)  98.17%Sequence  Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser- Val-Glu-Gly-Ser-Cys-Gly-Phe{MonoMolecular Formula C78H123N23O13S2Appearance Chemical SynthesisStorage Lyophilized FRAGMENT 176-191 is Stable at room Temperature for 90 days, however it is best to storer in   freeze below - 8c for any extended period of time. After reconstitution FRAGMENT 176-191 should be  refrigerated at temperatures not to exceed 35 F."Terms The products we offer are intended for laboratory research use only. Please familiarize yourself with our terms of service prior to ordering...

$26.00

IGF-1 LR3 1mg Magnus Pharma

IGF-1 LR3 (Receptor Grade) 1mgReceptor Grade IGF-1 LR3 is a premium research reagent for use in cell growth studies, IGF receptors and IGF binding proteins and is more potent than rH IGF-1 and Media Grade IGF-1 LR3 in-vitro due to the drastic increase in biological activity (stronger affinity for the IGF receptor). This increased biological activity is what sets Receptor Grade IGF-1 LR3 apart from Media Grade (standard) IGF-1 LR3. Media grade IGF-1 LR3 is more commonly used in commercial cell culture vs mammalian and can also be used as a research reagent at an economical cost to enable studies where biological potency is of less value. To maximize results in an animal-based in-vitro cell study or production, Receptor Grade IGF-1 LR3 should be used exclusively. The supplementation of mammalian cell cultures with Long R3 IGF-1 at a much lower concentration results in more highly elevated productivity than with standard concentrations of insulin and/or standard IGF-1. IGF-1 LR3 is better able to stimulate the type 1 IGF receptor and thus induce a higher level of intracellular signaling, cell proliferation and inhibition of apoptosis.Receptor Grade IGF-1 LR3 is more biologically active than standard IGF-1 LR3, in-vitro. Resultantly, Receptor Grade IGF-1 LR3 will deliver superior results in comparison to standard IGF-1 LR3.Sequence: MFPAMPLSSLFVNGPRTLCGAELVDALQFVCGDRGFYFNKPTGYGSSSRRAPQTGIV DECCFRSCDLRRLEMYCAPLKPAKSA Molar Mass: 9,111 Da Synonyms:Long r3 IGF-1, LR3 IGF, IGF1 LR3, Long Arg3 IGF-1IGF-1 LR3 (Long R3 IGF-1)IGFB Binding and The Increased Biological Activity of Long R3 IGF-1By resisting IGFBP-binding, IGF-1 LR3 has a greater effect than IGF-1. The longer duration of action allows for smaller amounts to be used with the same effects. Some IGF-1 derivatives, such as the GPE derivative, made up of just the last three N-terminal amino acids of the IGF-1 protein, have been shown to have therapeutic effects in neurological injuries like stroke. Most studies concerning the effects of IGF-1 derivatives have been carried out in non-human animal models or cell culture studies. The Sequence of IGF-1 LR3 and Muscle GrowthThe polypeptide Long R3 Insulin-like Growth Factor-I (IGF1 LR3) is an 83 amino acid analog of IGF-I actually comprising the complete IGF-1 sequence but with the substitution of an Arginine (Arg) for the Glutamic Acid (Glu) at position 3, as well as a 13 amino acid extension peptide. This sequence change causes IGF-1 LR3 to avoid binding to proteins and allow it to have a much longer half life, around 20-30 hours. This analog of IGF-1 has been produced with the purpose of increasing the biological activity of the IGF peptide.” IGF stands for insulin-like growth factor. Among the effects the most positive are increased amino acid transport to cells, increased glucose transport, increased protein synthesis, and decreased protein degradation. When IGF is active it behaves differently in different types of tissues. In muscle cells proteins and associated cell components are stimulated. Protein synthesis is increased along with amino acid absorption. As a source of energy, IGF-1 LR3 mobilizes fat for use as energy in adipose tissue. In lean tissue, IGF-1 LR3 prevents insulin from transporting glucose across cell membranes. As a result the cells have to switch to burning off fat as a source of energy.IGF-1 LR3 builds new muscle tissue by promoting nitrogen retention and protein synthesis. This causes the growth of muscles through both hyperplasia (which is an increase in number of muscle cells) and mitogenesis (which is the actual growth of new muscle fibers). Thus IGF-1 LR3 not only makes muscle fibers bigger, it makes more of them as well. Therefore, IGF can actually change the genetic capabilities in terms of muscle tissue and cell count. IGF increases and differentiates the number and types of cells present. IGF-1 LR3 is a synthetic analog of the naturally existing insulin growth factor (IGF) which is a 93 amino acid residue. Modifications of the natural form occurred with the substitution of the Arg with Glu at the position 3, giving a code R3, and also an extension of a 13 amino acid at the B-terminus. Just like IGF-1, R3 has been shown to induce the development and growth of cells.The studies on transgenic and knockout mice have shown that it can control its development and growth. It plays an important role as regulator in the G1 to S phase of the cell cycle. When applied to cardiomyocyte cultures, R3 have shown a large increase in proliferating cell nuclear antigen expression and in several cyclins involved in cell progression as well as in bromodeoxyuridien (BrdU) labeling (Kajstura et al. 1994). Other effects it has on cell lines are increased cell survival, inhibition of the apoptotic pathways, culture longevity and increased recombination of protein production (Fang et al. 1997). In another study, the application of the LR3 IGF-1 has led to an increase in the myocyte bromodeoxyuridine uptake by three to fivefold. But it has also shown that IGF-1 LR3 actions have been blocked by the ERK and P13K labeling which completely abolished the BrdU uptake. Furthermore, ut has been shown that in mycocytes, IGF-1 R3 stimulates the cardiomyocyte division in vivo (Sundgren et al. 2003). It has also been suggested that IGF-1-Long 3R is more potent than the IGF-1 because of its low binding capacity with all known IGF binding proteins (Tomas et al. 1995). In another investigation, feeding of LR3-IGF-1 in different amounts to investigate the effects on somatotropic axis (plasma levels of IGF-1 and 2, IGFBPs) was done. They have reported that plasma Long-R3 increased when administered subcutaneously but with no such behavior when administered orally. Furthermore, LR3 lowered the levels of native IGF-1 in rbGH-injected in calves, but L-R3 increased the amounts of IGF-II concentrations when administered with L-R3 subcutaneously. The parenteral administration of the Long R3 IGF-1 decreased the growth hormone concentration but did not affect the secretory system. It was also reported that the somatotrophic acis is basically functioning in neonatal calves and can be influenced by nutrition, growth hormone and Long-R3-IGF-1 (IGF1-LR3). (Hammon and Blum 1997).The Half-Life of IGF-1 LR3 and its Effects of IGF-1It has a considerably longer half-life than other form, nearly 20-30 hours. When IGF-1 LR3 is active, has multiple effects on tissues in muscle cells. It plays a essential role in muscle renewal. IGF-1 LR3 encourages both increase as well distinction of stem cells. IGF-1 LR3 increases satellite cell activity, muscle DNA, muscle protein content, muscle weight and muscle cross sectional area. The importance of IGF-1 LR3 lies in the fact that all of its obvious effects work to induce muscle growth. These effects are enhanced when combined with weight training.Protein creation is better along with amino acid absorption as a source of energy. It enhances use of fat as energy. In lean tissue, IGF-1 LR3 prevents insulin form carrying glucose across cell membranes, as a result, the cells have to change to burning off fat as a source of energy. IGF-1 LR3 also mimics insulin in the human body.Perhaps the most remarkable also strong influence it has on the human body is its ability to cause hyperplasia, which is an definite splitting of cells. Hypertrophy is what ensues during weight training; it is an increase in the size of muscle cells. Adult humans have a fixed number of muscle cells, that can become larger with training, however the number of muscle sells does not increase. But, with this preparation use you are able to induce hyperplasia which actually increases the number of muscle cells present in the muscle. Research studies show that with weight training the new cells develop faster and become stronger and more dense. IGF-1 LR3 used in CLINICAL RESEARCHIGF-1 LR3 plays an important part in childhood growth and continues to have results in adults. It is made in the human body and is at ideal levels during puberty. In most studies, the maximum active length for research studies IGF-1 LR3 is 50 days on also 20-40 days off. The most common range used during clinical research is typically between 20mcg to 120mcg per day.During puberty, IGF is the most responsible for the natural muscle growth that occurs during these few years. There are many different things that IGF does in the human body; among the effects the most positive are increased amino acid transport to cells, increased glucose transport, increased protein synthesis, decreased protein degradation and increased RNA synthesis. Perhaps the most interesting and potent effect IGF has on the human body is its ability to cause hyperplasia, which is an actual split-ting of cells.In muscle cells, proteins and their cell components are stimulated. Protein synthesis is increased along with amino acid absorption. As a source of energy, IGF-1 mobilizes fat for use as energy in adipose tissue. In lean tissue, IGF prevents insulin from transporting  glucose across cell membranes. As a result, the cells have to switch to burning off fat as a source of energy.  Research Use of IGF-1 LR3- enlarged amino acid transporting cells- increased protein production- reduced protein degradation- amplified glucose transporting- augmented RNA combination..

$61.00

Ipamorelin 5mg

PRODUCT USAGE:THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY.This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All the product information available on this website is for educational purposes only. Bodily introduction of any kind into huans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabled as a drug, food or cosmetics.IpamorelinIpamorelin is a penta-peptide hormone (Aib-His-D-2-Nal-D-Phe-Lys-NH2), a growth hormone secretagogue and a small molecule ghrelin mimetic developed by Novo Nordisk. Ipamorelin belongs to the most recent generation of GHRPs and causes significant release of growth hormone. Similar to GHRP-6 and GHRP-2, it suppresses somatostatin and increases the stimulation and release of Growth Hormone (GH) from the anterior pituitary. Currently, there are few clinical trials involving Ipamorelin, which were first being studied in the 90s. Somatotropes are the cells that are responsible for producing and releaseing GH.Ipamorelin PeptideSequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2Molecular formula: C38H49N9O5Molar Mass: 711.85296CAS number: 170851-70-4PubChem: CID 20754357Synonyms: Ipamorelin Acetate, IPAM, NNC-26-0161 The Ipamorelin Growth Hormone Releasing Peptide ComparisonIpamorelin is a 3rd generation GHRP behind GHRP-6 and GHRP-2. Ipamorelin has very similar characteristics of GHRP-2: does not have ghrelin's lipogenic properties and does not promote hunger. Ipamorelin acts synergistically when applied during a Growth Hormone Releasing Hormone (GHRH) pulse or when it is administered along with a GHRH or an analog such as Sermorelin or Modified GRF 1-29 (growth releasing factor, aminos 1-29). The synergy comes both due to the suppression of somatostatin and the fact that ipamorelin increases GH release per-somatotrope, while GHRH increases the number of somatotropes releasing GH. On the other hand, Ipamorelin is similar to GHRP-6 because they both release GH at a very similar strength minus the side effects that of GHRP-6. Both GHRP-6 and GHRP-2 cause a release and an increase in cortisol and prolactin levels, however Ipamorelin only selectively releases GH at any dose. Ipamorelin shares similar functionality to Hexarelin and compared to other peptides, it is a much more stable form of ghrelin and has longer half-life periods of at least two hours long and causes secondary effect by making neurons to become excited.Studies Related to IpamorelinIpamorelin has been shown to be both highly potent and very selective in vivo and vitro situations, and has also demonstrated good safety and tolerability in human clinical studies. Research has shown that Ipamorelin is growth hormone specific which means that the pituitary hormones such as cortisol are unaffected. In one study, it was found that young female adult rats had increased bone mass due to 12 weeks of treatment with ipamorelin. This peptide compared to other Growth Hormone Releasing Peptides ensures the benefits without having to deal with possible negative side effects...

$14.00

Ipamorelin 5mg Magnus Pharma

This drug belongs to the category of the peptide hormone drug class. Its main action is directed to the stimulation of the secretion of growth hormone.The characteristics of the drug can be called except that there is no visible change in the appetite of the man.Ipamorelin was synthesized in 1998 by replacing a fragment of GHRP and the introduction into the chain of elements such as GABA (gamma-aminobutyric acid), Histidine is dextro and 2-naphthylaminePeptides coursePreparation affects significantly the production of growth hormone. This hormone is the latest generation of this type of hormonal drugs.The maximum permitted dose of the drug is 100 micrograms. It is best to inject the medication in the body parts – 2 or 3 times a day. This is not only very convenient to host, but that it also allows you to concentrate better in preparation before the start of the action.On the other hand there to highlight the increase in dose. Studies have shown that the optimal dose of the drug (100 mg), receivers fully loaded. However, if the dose add the effect will be only 25% more. What does it mean? This means that, in principle, the addition of dose inadequate, since this will not lead to a difference in the final result.On the other hand, if blindly increasing the dose of the medication, will only lead to a reduction of its anabolic effect, and therefore such experiments are not feasible.It has its characteristics in the preparation and storage of the drug. You must cool down in any way, add some water so that it flows along the walls of the vial and mix the hands rotating in a circular motion. Do not move or shake the bottle with the liquid.In a cool place, such as a refrigerator freezer without transformation and preparation normally they can be stored for 20-25 days.Reviews peptidesIf we look at the responses of athletes, we can see that the majority is trying to compare a drug with other similar substances. In principle, they can be used together in a course of combined type.If it is scanned with other hormones, it can be concluded that this drug is the best of all others, since it is considered to be the safest. Even in the case of high doses which practically does not increase the production of cortisol and prolactin.It is precisely a new peptide, which is able to solve many problems.Peptides side effectsAs mentioned previously, this preparation is basically recognized as one of the safer even for the Fund similar preparations. Why? This is achieved through a special structural formula, in the more pronounced anabolic effect and an impact moderated on the human body.Unlike many other drugs, the course of peptide practically does not need additional operations to prepare the body for the course. Basically, for those who want to be safe, once again, it is possible to pass a medical exam and need to verify the absence of, for example, an allergic reaction components of the drug in the body of the athlete.Another feature, having peptide is the increase in phases of deep sleep, implying a greater natural production of natural growth hormone.Buying peptides onlineIf you are looking where to buy quality hormones, we recommend to pay attention to our online store. Why? Since we can guarantee the quality of our products, the price is the lowest in us. A lot of positive feedback is proof of this. We have confidence in the quality of our products and we can safely guarantee their quality.Only here is the opportunity to receive additional bonuses, who came to the club from our loyal customers. Write your comments, leave them on our website. We would appreciate the views and desires of each client. In this way, it will help make our work better and more effective and more enjoyable for you. Our store has the range schirokim of drugs on the market. Because of this any buyer can be purchased by itself a drug which is more closer to your needs. By contacting with us, you won’t regret it. No, we have been knowing the title of the most popular and reliable supplier. Through our work hundreds of bodybuilders have been able to achieve their dreams – has a beautiful and powerful body. Picking can be on our website or call for help. Hurry, since the supply of our actions is limited! Have time to buy the drug, to be the first to feel the results for yourself...

$63.00

Showing 1 to 12 of 16 (2 Pages)